Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Report 2025

The artificial intelligence (AI)-powered acute stroke triage market size has grown exponentially in recent years. It will grow from $1.41 billion in 2024 to $1.72 billion in 2025 at a compound annual growth rate (CAGR) of 22.5%. The growth during the historic period is driven by rising stroke incidence among the aging population, increasing burden of stroke-related mortality and morbidity, higher prevalence of chronic diseases, expansion of government awareness programs, and growth of healthcare infrastructure.

The artificial intelligence (AI)-powered acute stroke triage market size is expected to see exponential growth in the next few years. It will grow to $3.83 billion in 2029 at a compound annual growth rate (CAGR) of 22.2%. The projected growth in the forecast period is supported by increasing healthcare investments in stroke care, greater adoption of stroke management strategies, expanded healthcare access in emerging markets, rising public awareness of stroke symptoms, and stronger emphasis on early medical intervention. Key trends in this period include advancements in imaging analysis, development of AI-based decision support platforms, innovations in mobile stroke units, investment in cloud-based healthcare solutions, integration of telemedicine in research and development, and progress in virtual reality training for medical personnel.

The increasing occurrence of stroke is expected to drive the growth of the artificial intelligence (AI)-powered acute stroke triage market. A stroke happens when the blood flow to the brain is disrupted, leading to cell damage and potentially resulting in disability or death if not addressed quickly. Hypertension plays a significant role in the rising incidence of stroke, as high blood pressure heightens the risk of blockages or ruptures in brain vessels. AI-powered acute stroke triage systems assist in diagnosing strokes by quickly analyzing brain scans, which is vital for early identification of stroke type and severity. These systems reduce diagnostic delays by prioritizing urgent cases, speeding up treatment and improving patient outcomes. For example, in September 2024, the Stroke Foundation, an Australia-based non-profit, reported that in 2023, about 45,785 Australians experienced a stroke, with one stroke occurring every 11 minutes. Of these, 34,793 were first-time occurrences. As a result, the rising incidence of stroke is driving the growth of AI-powered acute stroke triage technologies.

Leading companies in the artificial intelligence (AI)-powered acute stroke triage market are focused on developing advanced solutions, such as AI algorithms, to improve diagnostic precision, speed up triage processes, and enhance clinical results. These AI algorithms use sophisticated computational methods to analyze data, identify patterns, make predictions, and assist in decision-making. For instance, in April 2023, RapidAI Inc., a US-based provider of cerebrovascular imaging solutions, received US Food and Drug Administration (FDA) 510(k) clearance for Rapid Noncontrast Computed Tomography (NCCT) Stroke. This AI solution aids in detecting suspected intracranial hemorrhage (ICH) and large vessel occlusion (LVO) using standard CT scans. The system automatically processes NCCT images and sends triage alerts through PACS, email, and the Rapid mobile app, reducing the time between door-to-imaging and door-to-decision. It also supports quicker transfer and treatment decisions, minimizes delays for advanced imaging, and improves access to stroke care at hospitals of all levels.

In February 2023, Bayer AG, a German life sciences company, acquired Blackford Analysis Ltd., a UK-based company specializing in AI-powered imaging solutions for acute stroke triage, for an undisclosed amount. The acquisition allows Bayer to expand its AI imaging capabilities by integrating Blackford’s imaging platform with Bayer’s global resources. This merger aims to improve clinical workflows, enhance diagnostic efficiency, and elevate patient care while preserving innovation in the field.

Major players in the artificial intelligence (AI)-powered acute stroke triage market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Shanghai United Imaging Healthcare Co. Ltd., Viz.ai Inc., Aidoc Medical Ltd., RapidAI Inc., Qure.ai Technologies Private Limited, Harrison.ai Pty Ltd, Infervision Inc., Circle Cardiovascular Imaging Inc., Behold.ai Ltd., Brainomix Ltd., JLK Inc., BioMind.ai Pte. Ltd., Sevaro Health Inc., Heuron Technologies Inc., Nicolab Inc., icometrix NV, Deep01 Inc., SNAC Medical Inc., BrainScan.ai Ltd., Cercare Medical Ltd., and Avicenna.AI GmbH.

North America was the largest region in the artificial intelligence (AI)-powered acute stroke triage market in 2024. The regions covered in artificial intelligence (AI)-powered acute stroke triage report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the artificial intelligence (AI)-powered acute stroke triage market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Artificial intelligence (AI)-powered acute stroke triage is a medical technology that uses AI algorithms to quickly analyze brain imaging and patient information for suspected stroke cases. Its main function is to determine stroke type, assess severity, and detect large vessel occlusions in real time, supporting faster clinical decision-making.

The primary components of AI-powered acute stroke triage include software, hardware, and services. The software consists of AI-driven programs that automatically review brain scans, identify stroke indicators, prioritize urgent cases, and assist healthcare professionals in making quicker treatment decisions. These solutions can be deployed on-premises or in cloud-based environments and are applied in hospitals, diagnostic centers, emergency medical services, research institutes, and similar settings. Key end users include healthcare providers, radiology centers, academic and research institutions, and other relevant organizations.

The artificial intelligence (AI)-powered acute stroke triage market research report is one of a series of new reports that provides artificial intelligence (AI)-powered acute stroke triage market statistics, including the artificial intelligence (AI)-powered acute stroke triage industry global market size, regional shares, competitors with the artificial intelligence (AI)-powered acute stroke triage market share, detailed artificial intelligence (AI)-powered acute stroke triage market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered acute stroke triage industry. This artificial intelligence (AI)-powered acute stroke triage market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI)-powered acute stroke triage market includes revenues earned by entities by providing services such as real-time stroke detection and analysis, automated imaging interpretation, clinical decision support, tele-radiology consultations, and workflow optimization for rapid treatment initiation. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-powered acute stroke triage market also includes sales of computed tomography (CT) scanners, magnetic resonance imaging (MRI) machines, integrated stroke detection systems, and cloud-based triage solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.